BLOCKADE OF BCL-2 PROTEINS EFFICIENTLY INDUCES APOPTOSIS IN PROGENITOR CELLS OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (MDS) PATIENTS

被引：1
|
作者：
Jilg, S. [1 ]
Reidel, V. [1 ]
Mueller-Thomas, C. [1 ]
Koenig, J. [1 ]
Schauwecker, J. [2 ]
Burgkart, R. [2 ]
Hoeckendorf, U. [1 ]
Huberle, C. [1 ]
Gorka, O. [3 ]
Ruland, J. [3 ]
Kolb, H. [1 ]
Peschel, C. [1 ]
Oostendorp, R. [1 ]
Goetze, K. [1 ]
Jost, P. [1 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 3, D-80290 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Orthoped, D-80290 Munich, Germany
[3] Tech Univ Munich, Klinikum Rechts Isar, Dept Clin Chem, D-80290 Munich, Germany
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
10.1016/S0145-2126(15)30028-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
27
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [21] Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins
    Adams, JM
    Huang, DCS
    Puthalakath, H
    Bouillet, P
    Vairo, G
    Moriishi, K
    Hausmann, G
    O'Reilly, L
    Newton, K
    Ogilvy, S
    Bath, ML
    Print, CG
    Harris, AW
    Strasser, A
    Cory, S
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1999, 64 : 351 - 358
  • [22] In vivo mobilization of karyotypically normal peripheral blood progenitor cells (PBPC) in high-risk myelodysplastic syndromes.
    Celesti, L
    Dejana, A
    Lerma, E
    Fugazza, G
    Sessarego, M
    Podesta, M
    Frassoni, F
    Valbonesi, M
    Carella, AM
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 360 - 360
  • [23] BCL-2 EXPRESSION BY MYELOID PRECURSORS IN MYELODYSPLASTIC SYNDROMES (MDS) - IMMUNOSTAINING OF BONE-MARROW (BM) BIOPSIES
    DAVIS, RE
    GREENBERG, PL
    BLOOD, 1994, 84 (10) : A314 - A314
  • [24] BCL-2 inhibitor APG-2575 and homoharringtonine (HHT) synergistically induces apoptosis and inhibits tumor growth in preclinical models of acute myeloid leukemia and myelodysplastic syndromes (AML/MDS).
    Fang, Douglas D.
    Tang, Qiuqiong
    Kong, Yanhui
    Rong, Tao
    Wang, Qixin
    Deng, Jing
    Yang, Dajun
    Zhai, Yifan
    CANCER RESEARCH, 2021, 81 (13)
  • [25] Phase II Study of the IDH2 Inhibitor Enasidenib in Patients with High-Risk IDH2-Mutated Myelodysplastic Syndromes (MDS)
    Venugopal, Sangeetha
    DiNardo, Courtney D.
    Takahashi, Koichi
    Konopleva, Marina
    Loghavi, Sanam
    Borthakur, Gautam
    DeZern, Amy
    Masarova, Lucia
    Daver, Naval
    Short, Nicholas J.
    Alvarado, Yesid
    Ravandi, Farhad
    Montalban-Bravo, Guillermo
    Sasaki, Koji
    Delumpa, Ricardo
    Sekeres, Mikkael A.
    Patel, Bhumika
    Roboz, Gail J.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S339 - S339
  • [26] Phase II study of the IDH2-inhibitor enasidenib in patients with high-risk IDH2-mutated myelodysplastic syndromes (MDS).
    Venugopal, Sangeetha
    Dinardo, Courtney Denton
    Takahashi, Koichi
    Konopleva, Marina
    Loghavi, Sanam
    Borthakur, Gautam
    Dezern, Amy Elizabeth
    Masarova, Lucia
    Daver, Naval Guastad
    Short, Nicholas James
    Alvarado, Yesid
    Ravandi, Farhad
    Montalban-Bravo, Guillermo
    Sasaki, Koji
    Delumpa, Ricardo
    Sekeres, Mikkael A.
    Patel, Bhumika J.
    Roboz, Gail J.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins
    Sun, Bao Sheng
    Wang, Jiang Huai
    Liu, Lin Lin
    Gong, Shou Hang
    Redmond, H. Paul
    JOURNAL OF SURGICAL ONCOLOGY, 2007, 96 (03) : 241 - 248
  • [28] Zeaxanthin Induces Apoptosis in Human Uveal Melanoma Cells through Bcl-2 Family Proteins and Intrinsic Apoptosis Pathway
    Bi, Ming-Chao
    Rosen, Richard
    Zha, Ren-Yuan
    McCormick, Steven A.
    Song, E.
    Hu, Dan-Ning
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [29] Arsenic trioxide induces apoptosis in T cells by oxidative stress and regulation of Bcl-2 family proteins
    Gollapudi, SV
    Kim, D
    Chiplunkar, S
    Gupta, S
    FASEB JOURNAL, 2002, 16 (04): : A342 - A342
  • [30] 'Low risk' myelodysplastic syndrome (MDS) is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic Bcl-2 related proteins.
    Parker, JE
    Fishlock, KL
    Mijovic, A
    Pagliuca, A
    Mufti, GJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 105 - 105
12345